美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=NEOSTIGMINE METHYLSULFATE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
NEOSTIGMINE METHYLSULFATE 203629 001 NDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) Yes Yes 2015/01/08 2015/01/08 FRESENIUS KABI USA Prescription
NEOSTIGMINE METHYLSULFATE 203629 002 NDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) Yes Yes 2015/01/08 2015/01/08 FRESENIUS KABI USA Prescription
NEOSTIGMINE METHYLSULFATE 203629 003 NDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 3MG/3ML (1MG/ML) Yes Yes 2015/01/08 2018/09/18 FRESENIUS KABI USA Prescription
NEOSTIGMINE METHYLSULFATE 207042 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2015/12/28 2015/12/28 HIKMA Prescription
NEOSTIGMINE METHYLSULFATE 207042 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2015/12/28 2015/12/28 HIKMA Prescription
NEOSTIGMINE METHYLSULFATE 208405 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2017/04/26 2017/04/26 ENDO OPERATIONS Prescription
NEOSTIGMINE METHYLSULFATE 208405 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2017/04/26 2017/04/26 ENDO OPERATIONS Prescription
NEOSTIGMINE METHYLSULFATE 209933 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2017/09/25 2017/09/25 AMPHASTAR PHARMS INC Prescription
NEOSTIGMINE METHYLSULFATE 209933 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2017/09/25 2017/09/25 AMPHASTAR PHARMS INC Prescription
NEOSTIGMINE METHYLSULFATE 209182 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2018/05/04 2018/05/04 AM REGENT Discontinued
NEOSTIGMINE METHYLSULFATE 209182 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2018/05/04 2018/05/04 AM REGENT Discontinued
NEOSTIGMINE METHYLSULFATE 210051 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2018/06/15 2018/06/15 AMNEAL Prescription
NEOSTIGMINE METHYLSULFATE 210051 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2018/06/15 2018/06/15 AMNEAL Prescription
NEOSTIGMINE METHYLSULFATE 209135 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2018/07/10 2018/07/10 DR REDDYS Prescription
NEOSTIGMINE METHYLSULFATE 209135 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2018/07/10 2018/07/10 DR REDDYS Prescription
NEOSTIGMINE METHYLSULFATE 210989 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2018/08/22 2018/08/22 AMRING PHARMS Prescription
NEOSTIGMINE METHYLSULFATE 210989 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2018/08/22 2018/08/22 AMRING PHARMS Prescription
NEOSTIGMINE METHYLSULFATE 212512 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2019/05/13 2019/05/13 BE PHARMS Prescription
NEOSTIGMINE METHYLSULFATE 212512 002 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 10MG/10ML (1MG/ML) No No 2019/05/13 2019/05/13 BE PHARMS Prescription
NEOSTIGMINE METHYLSULFATE 212968 001 ANDA NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS 5MG/10ML (0.5MG/ML) No No 2019/10/16 2019/10/16 GLAND PHARMA LTD Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database